Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference
Karyopharm Therapeutics (Nasdaq: KPTI), a commercial-stage pharmaceutical company focused on novel cancer therapies, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference. The company's senior management team will engage in a fireside chat on Tuesday, December 3 at 11:30 a.m. ET in New York.
The event will be accessible via live webcast in the Investor section of Karyopharm's website under 'Events & Presentations,' with replay availability after the event.
Karyopharm Therapeutics (Nasdaq: KPTI), un'azienda farmaceutica in fase commerciale focalizzata su terapie innovative per il cancro, ha annunciato la sua partecipazione alla 36ª Conferenza Annuale sulla Salute di Piper Sandler. Il team di gestione senior dell'azienda parteciperà a una chiacchierata informale martedì 3 dicembre alle 11:30 ET a New York.
L'evento sarà accessibile tramite webcast dal vivo nella sezione Investor del sito web di Karyopharm sotto 'Eventi e Presentazioni', con disponibilità di replay dopo l'evento.
Karyopharm Therapeutics (Nasdaq: KPTI), una empresa farmacéutica en etapa comercial centrada en terapias novedosas contra el cáncer, ha anunciado su participación en la 36ª Conferencia Anual de Salud de Piper Sandler. El equipo de alta dirección de la compañía participará en una charla informal el martes 3 de diciembre a las 11:30 a.m. ET en Nueva York.
El evento será accesible a través de una transmisión en vivo en la sección de Inversores del sitio web de Karyopharm en 'Eventos y Presentaciones', con disponibilidad de repetición después del evento.
카리오파름 테라퓨틱스 (Nasdaq: KPTI)는 혁신적인 암 치료에 중점을 둔 상업 단계의 제약 회사로, 파이퍼 샌들러 제36회 연례 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 고위 경영진 팀은 12월 3일 화요일 오전 11시 30분 ET에 뉴욕에서 화기애애한 대화에 참여할 예정입니다.
이벤트는 Karyopharm 웹사이트의 투자자 섹션 '이벤트 및 발표'에서 라이브 웹캐스트를 통해 접근 가능하며, 이벤트 이후 재생 가능성이 있습니다.
Karyopharm Therapeutics (Nasdaq: KPTI), une entreprise pharmaceutique en phase commerciale axée sur de nouvelles thérapies contre le cancer, a annoncé sa participation à la 36e Conférence Annuelle de Santé Piper Sandler. L'équipe de direction senior de l'entreprise participera à une discussion informelle le mardi 3 décembre à 11h30 ET à New York.
L'événement sera accessible via un webinaire en direct dans la section Investisseurs du site Web de Karyopharm dans 'Événements et Présentations', avec une disponibilité de rediffusion après l'événement.
Karyopharm Therapeutics (Nasdaq: KPTI), ein kommerzielles Pharmaunternehmen, das sich auf neuartige Krebstherapien konzentriert, hat seine Teilnahme an der 36. jährlichen Piper Sandler Gesundheitskonferenz angekündigt. Das Senior Management Team des Unternehmens wird am Dienstag, den 3. Dezember um 11:30 Uhr ET in New York an einem informellen Gespräch teilnehmen.
Die Veranstaltung wird über einen Live-Webcast im Investorenbereich der Karyopharm-Website unter 'Veranstaltungen & Präsentationen' zugänglich sein, mit Wiederholungsmöglichkeiten nach der Veranstaltung.
- None.
- None.
A live webcast of the fireside chat can be accessed under "Events & Presentations" in the Investor section of the Company's website, https://investors.karyopharm.com/events-presentations, and will be available for replay following the event.
About Karyopharm Therapeutics
Karyopharm Therapeutics Inc. (Nasdaq: KPTI) is a commercial-stage pharmaceutical company whose dedication to pioneering novel cancer therapies is fueled by a belief in the extraordinary strength and courage of patients with cancer. Since its founding, Karyopharm has been an industry leader in oral compounds that address nuclear export dysregulation, a fundamental mechanism of oncogenesis. Karyopharm's lead compound and first-in-class, oral exportin 1 (XPO1) inhibitor, XPOVIO® (selinexor), is approved in the
XPOVIO® and NEXPOVIO® are registered trademarks of Karyopharm Therapeutics Inc. Any other trademarks referred to in this release are the property of their respective owners.
View original content to download multimedia:https://www.prnewswire.com/news-releases/karyopharm-to-participate-at-the-piper-sandler-36th-annual-healthcare-conference-302314838.html
SOURCE Karyopharm Therapeutics Inc.
FAQ
When is Karyopharm (KPTI) presenting at the Piper Sandler Healthcare Conference?
How can I watch Karyopharm's (KPTI) presentation at the Piper Sandler Conference?
What type of presentation will Karyopharm (KPTI) give at the Piper Sandler Conference?
Will Karyopharm's (KPTI) Piper Sandler Conference presentation be available for replay?
